Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement Varga, A., Camidge, D. R., Sequist, L. V., Wakelee, H., Ou, S. H., Goldman, J. W., Papadimitrakopoulou, V., Gadgeel, S., Mekhail, T., Oxnard, G. R., Socinski, M., Solomon, B., Yu, H., Matheny, S., Despain, D., Soria, J. C. ELSEVIER SCI LTD. 2015: S598
View details for DOI 10.1016/S0959-8049(16)31654-9
View details for Web of Science ID 000361887402546